v3.25.4

COMMITMENTS AND CONTINGENCIES - Narrative (Details) $ in Millions | Dec. 31, 2025 USD ($)
--- | ---
Other commitments |
Capital expenditures | $ 128
Milestone payments in terms of collaboration and license agreements, aggregate | 242
Accrued milestone payments under acquisition and licensing arrangements | 37
Novaliq GmbH |
Other commitments |
Milestone payments in terms of collaboration and license agreements, aggregate | 88
Whitecap Biosciences |
Other commitments |
Aggregate milestone payments under acquisition and licensing arrangements | 64
Unnamed Seller For December 2025 Manufacturing Equipment Acquisition |
Other commitments |
Aggregate milestone payments under acquisition and licensing arrangements | $ 35

X
- Definition Accrued Milestone Payments Under Acquisition And Licensing Arrangements + References No definition available. + Details
Name: | blco_AccruedMilestonePaymentsUnderAcquisitionAndLicensingArrangements
Namespace Prefix: | blco_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Represents the amounts required to be paid by the reporting entity, which are contingent upon the achievement of specific development, regulatory or commercial milestones, in connection with the Collaboration Agreement. + References No definition available. + Details
Name: | blco_CollaborativeAgreementMilestonePaymentsAggregate
Namespace Prefix: | blco_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Milestone Payments Under Acquisition And Licensing Arrangements, Aggregate + References No definition available. + Details
Name: | blco_CollaborativeArrangementMilestonePaymentsUnderAcquisitionAndLicensingArrangementsAggregate
Namespace Prefix: | blco_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition -- None. No documentation exists for this element. -- + References No definition available. + Details
Name: | blco_ScheduleOfCommitmentsLineItems
Namespace Prefix: | blco_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of contractual obligation, including, but not limited to, long-term debt, lease obligation, purchase obligation, and other commitments. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 942 -SubTopic 235 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3 + Details
Name: | us-gaap_ContractualObligation
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | srt_CounterpartyNameAxis=blco_NovaliqGmbHMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=blco_WhitecapBiosciencesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=blco_UnnamedSellerForDecember2025ManufacturingEquipmentAcquisitionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |